Ranked by engagement
Top topics — all time page 18
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 18 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Conditions that change the calculus rather than forbidding it
Posting this under the heading it deserves: Conditions that change the calculus rather than forbidding it Everything below is what sits behind that. I was wrong about Conditions in a thread last spring and I…
|
+30 | 34 | 62k | 2y |
|
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1 rather than a conclusion. I would rather…
|
+70 | 76 | 4.8k | 15h |
|
Bioimpedance and hydration: why the number moves
Bioimpedance and hydration: why the number moves — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin bioimpedance and hydration down and I want to set…
|
+62 | 70 | 13k | 23d |
|
Checking someone else's arithmetic: a worked example thread
Checking someone else's arithmetic: a worked example thread Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+74 | 78 | 895 | 11mo |
|
Regression to the mean in progress reports
On the subject in the title: Regression to the mean in progress reports Working notes rather than a conclusion. Something about regression does not reconcile and I would like a second pair of eyes before I…
|
+30 | 34 | 49k | 12mo |
|
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs matter
Delayed gastric emptying and oral medication absorption: which drugs matter Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here…
|
+63 | 74 | 11k | 1d |
|
A 10 mg vial reconstituted three different ways, compared
Posting this under the heading it deserves: A 10 mg vial reconstituted three different ways, compared Everything below is what sits behind that. Something about 10 mg vial reconstituted three does not…
|
+30 | 34 | 55k | 17h |
|
Washout: how long is long enough, and for what purpose
Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A narrow question about washout, deliberately narrow, because the broad version has…
|
+63 | 70 | 13k | 10mo |
|
A calculator that gives a right answer to the wrong question — does this still hold?
A calculator that gives a right answer to the wrong question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the calculation with the…
|
+23 | 27 | 62k | 8mo |
|
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about the phase almost nobody writes…
|
+22 | 26 | 57k | 5mo |
|
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
|
+58 | 64 | 9.7k | 2mo |
|
Pages past their review date, listed — does this still hold?
Pages past their review date, listed — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to disagree carefully with the settled view…
|
+27 | 31 | 52k | 15mo |
|
Revisiting: PCOS and metabolic overlap: what is and is not studied
Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on PCOS and metabolic…
|
+55 | 59 | 26k | 2d |
|
Second pass at: How to research a compound with no human data without deceiving yourself
Second pass at: How to research a compound with no human data without deceiving yourself Writing it up because I had to work it out twice and would rather nobody else did. The question about research a…
|
+64 | 71 | 2.5k | 13mo |
|
Lipase elevation without symptoms: the interpretation problem
Lipase elevation without symptoms: the interpretation problem Writing it up because I had to work it out twice and would rather nobody else did. Lipase elevation without symptoms — I have the observation and…
|
+21 | 25 | 62k | 5mo |
|
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Pooling trials with different…
|
+57 | 64 | 12k | 7mo |
|
Revisiting: GLP-1 receptor distribution: central and peripheral
Revisiting: GLP-1 receptor distribution: central and peripheral — setting out what I have, and where I think it stops being reliable. An honest uncertainty about GLP-1 receptor distribution rather than a…
|
+61 | 66 | 15k | 8mo |
|
Publishing an inconvenient result: a case study
On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Publishing an inconvenient result, and specifically the version of it that the…
|
+59 | 70 | 992 | 11mo |
|
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. I was wrong about compounding permissions in a thread last…
|
+72 | 77 | 1.5k | 1d |
|
Coming back to: A structured critique template this community uses
Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that. Reading back through what has been written here about structured…
|
+63 | 69 | 17k | 18h |
|
Tirzepatide molecular mass and the charge states you would expect on ESI
Tirzepatide molecular mass and the charge states you would expect on ESI Writing it up because I had to work it out twice and would rather nobody else did. Tirzepatide molecular mass keeps being re-asked here…
|
+36 | 40 | 44k | 11mo |
|
Fibre intake when total intake falls, and the constipation link
Fibre intake when total intake falls, and the constipation link — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on fibre intake. The general…
|
+61 | 66 | 12k | 15mo |
|
Sample handling between despatch and injection
Sample handling between despatch and injection Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as evidence on sample handling between…
|
+63 | 68 | 2.4k | 3mo |
|
The best-written scientific paper you have read
The best-written scientific paper you have read Writing it up because I had to work it out twice and would rather nobody else did. Asking about best-written scientific paper directly, because I have read four…
|
+69 | 74 | 1.1k | 2mo |
|
Talking to a therapist about this specifically — does this still hold?
The question in the title: Talking to a therapist about this specifically — does this still hold? I will give what I have already checked below so nobody repeats it. A question about the part of this that…
|
+59 | 65 | 13k | 14mo |
|
Request: export my own posts — one year on
Request: export my own posts — one year on — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about export. Everyone quotes the same figure…
|
+61 | 70 | 14k | 4mo |
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
|
+70 | 74 | 7k | 8mo |
|
Splitting a vial for two laboratories: how to do it without ruining both
Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. Something about splitting a vial does not reconcile and I would…
|
+64 | 70 | 4.4k | 13mo |
|
What to include when your question involves a chromatogram — one year on
Asking directly, because I could not find a straight answer: What to include when your question involves a chromatogram — one year on Question in the title. Context below, and I have tried to include the…
|
+69 | 75 | 862 | 14d |
|
Revisiting: Mean kinetic temperature explained without the mathematics
Revisiting: Mean kinetic temperature explained without the mathematics Writing it up because I had to work it out twice and would rather nobody else did. A methods question rather than a substantive one,…
|
+67 | 75 | 909 | 2mo |